These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26296953)

  • 21. Marked for death: targeting epigenetic changes in cancer.
    Pfister SX; Ashworth A
    Nat Rev Drug Discov; 2017 Apr; 16(4):241-263. PubMed ID: 28280262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic drugs take on cancer.
    Kaiser J
    Science; 2010 Oct; 330(6004):576-8. PubMed ID: 21030620
    [No Abstract]   [Full Text] [Related]  

  • 23. Alteration of DNA Methylation in Gastric Cancer with Chemotherapy.
    Choi SJ; Jung SW; Huh S; Chung YS; Cho H; Kang H
    J Microbiol Biotechnol; 2017 Aug; 27(8):1367-1378. PubMed ID: 28621113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rockets, radiosensitizers, and RRx-001: an origin story part I.
    Oronsky B; Scicinski J; Ning S; Peehl D; Oronsky A; Cabrales P; Bednarski M; Knox S
    Discov Med; 2016 Mar; 21(115):173-80. PubMed ID: 27115167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic opportunities and challenges in cancer.
    Best JD; Carey N
    Drug Discov Today; 2010 Jan; 15(1-2):65-70. PubMed ID: 19897050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic cancer therapy makes headway.
    Mack GS
    J Natl Cancer Inst; 2006 Oct; 98(20):1443-4. PubMed ID: 17047192
    [No Abstract]   [Full Text] [Related]  

  • 27. Preclinical evaluation of the metabolism and disposition of RRx-001, a novel investigative anticancer agent.
    Scicinski J; Oronsky B; Taylor M; Luo G; Musick T; Marini J; Adams CM; Fitch WL
    Drug Metab Dispos; 2012 Sep; 40(9):1810-6. PubMed ID: 22699395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of a combination of selamectin plus sarolaner for the treatment and prevention of flea infestations and the treatment of ear mites in cats presented as veterinary patients in the United States.
    Vatta AF; Myers MR; Rugg JJ; Chapin S; Pullins A; King VL; Rugg D
    Vet Parasitol; 2019 Jun; 270 Suppl 1():S3-S11. PubMed ID: 30579753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the specific epigenetic alterations associated with chemo-resistance via reprogramming of cancer cells.
    Kim JJ; Rai R
    Med Hypotheses; 2015 Dec; 85(6):710-4. PubMed ID: 26527497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and classes of epigenetic drugs for cancer.
    Dhanak D; Jackson P
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):58-69. PubMed ID: 25016182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic alterations as a universal feature of cancer hallmarks and a promising target for personalized treatments.
    Schnekenburger M; Florean C; Dicato M; Diederich M
    Curr Top Med Chem; 2016; 16(7):745-76. PubMed ID: 26303418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemo control.
    Interlandi J
    Sci Am; 2007 Apr; 296(4):24. PubMed ID: 17479623
    [No Abstract]   [Full Text] [Related]  

  • 33. Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker.
    Teodoridis JM; Strathdee G; Brown R
    Drug Resist Updat; 2004; 7(4-5):267-78. PubMed ID: 15533764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001.
    Scicinski J; Oronsky B; Ning S; Knox S; Peehl D; Kim MM; Langecker P; Fanger G
    Redox Biol; 2015 Dec; 6():1-8. PubMed ID: 26164533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plant-derived epigenetic modulators for cancer treatment and prevention.
    Schnekenburger M; Dicato M; Diederich M
    Biotechnol Adv; 2014 Nov; 32(6):1123-32. PubMed ID: 24699435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flavonoids influence epigenetic-modifying enzyme activity: structure - function relationships and the therapeutic potential for cancer.
    Gilbert ER; Liu D
    Curr Med Chem; 2010; 17(17):1756-68. PubMed ID: 20345345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human DNA (cytosine-5)-methyltransferases: a functional and structural perspective for epigenetic cancer therapy.
    Rondelet G; Wouters J
    Biochimie; 2017 Aug; 139():137-147. PubMed ID: 28600135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic therapy for solid tumors: from bench science to clinical trials.
    Juo YY; Gong XJ; Mishra A; Cui X; Baylin SB; Azad NS; Ahuja N
    Epigenomics; 2015; 7(2):215-35. PubMed ID: 25942532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promises and challenges of anticancer drugs that target the epigenome.
    Verbrugge I; Johnstone RW; Bots M
    Epigenomics; 2011 Oct; 3(5):547-65. PubMed ID: 22126246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting components of epigenome by small molecules.
    You JS; Han JH
    Arch Pharm Res; 2014 Nov; 37(11):1367-74. PubMed ID: 25070764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.